Research Participation in Inflammatory Bowel Disease Studies: What Do Patients Want?
We found a low rate of interest in participating in placebo-controlled IBD clinical trial research but nearly 50% would participate in clinical trial research receiving active drug and 80% would participate in observational research. Research participation interest, however, was further lessened by the COVID pandemic.
Authors
- Çharles N. Bernstein (ORCID: https://orcid.org/0000-0001-8041-3574)
- Zoann Nugent
- Gia Ly
- Lesley A. Graff (ORCID: https://orcid.org/0000-0002-0743-3189)
- Harminder Singh (ORCID: https://orcid.org/0000-0002-9354-2356)
- Seth R. Shaffer (ORCID: https://orcid.org/0000-0002-9872-6832)
Institutions
- Manitoba Health (CA)
- University of Manitoba (CA)
Publication Details
- Journal
- Crohn s & Colitis 360
- Published
- 2025-02-27
- DOI
- https://doi.org/10.1093/crocol/otaf016
- Primary Topic
- Inflammatory Bowel Disease
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Pfizer
- Takeda Canada